DIAMOND OFFSHORE DRILLING, INC. 5.875% Senior Notes due 2019 Underwriting Agreement
Exhibit
1.1
$500,000,000
DIAMOND OFFSHORE DRILLING, INC.
5.875% Senior Notes due 2019
Underwriting Agreement
April 29, 2009
X.X. Xxxxxx Securities Inc.
Xxxxxxx, Sachs & Co.
Xxxxxxx, Sachs & Co.
As Representatives of the
several Underwriters listed
in Schedule 1 hereto
several Underwriters listed
in Schedule 1 hereto
c/o X.X. Xxxxxx Securities Inc.
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Ladies and Gentlemen:
Diamond Offshore Drilling, Inc., a Delaware corporation (the “Company”), proposes to issue and
sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are
acting as representatives (the “Representatives”), $500,000,000 principal amount of its 5.875%
Senior Notes due 2019 (the “Securities”). The Securities will be issued pursuant to an Indenture
dated as of February 4, 1997 (the “Base Indenture”), as supplemented by a sixth supplemental
indenture to be dated as of May 4, 2009 (the “Supplemental Indenture” and, together with the Base
Indenture, the “Indenture”) between the Company and The Bank of New York Mellon (formerly known as
The Bank of New York) (as successor under the Indenture to The Chase Manhattan Bank), as trustee
(the “Trustee”).
The Company hereby confirms its agreement with the several Underwriters concerning the
purchase and sale of the Securities, as follows:
1. Registration Statement. The Company has prepared and filed with the Securities and
Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, and the rules
and regulations of the Commission thereunder (collectively, the “Securities Act”), a registration
statement on Form S-3 (File No. 333-157865), including a prospectus (the “Base Prospectus”),
relating to the debt securities and other securities to be issued from time to time by the Company.
The Company has also filed, or proposes to file, with the Commission pursuant to Rule 424 under
the Securities Act a prospectus supplement specifically relating to the Securities (the
“Prospectus Supplement”). The registration statement, as amended at the time it becomes
effective, including the information, if any, deemed pursuant to Rule 430A, 430B or 430C under the
Securities Act to be part of the registration statement at the time of its effectiveness (“Rule 430
Information”), is referred to herein as the “Registration Statement”; and as used herein, the term
“Prospectus” means the Base Prospectus as supplemented by the prospectus supplement specifically
relating to the Securities in the form first used (or made available upon request of purchasers
pursuant to Rule 173 under the Securities Act) in connection with confirmation of sales of the
Securities and the term “Preliminary Prospectus” means the preliminary prospectus supplement
specifically relating to the Securities together with the Base Prospectus. If the Company has
filed an abbreviated registration statement pursuant to Rule 462(b) under the Securities Act (the
“Rule 462 Registration Statement”), then any reference herein to the term “Registration Statement”
shall be deemed to include such Rule 462 Registration Statement. Capitalized terms used but not
defined herein shall have the meanings given to such terms in the Registration Statement and the
Prospectus. References herein to the Registration Statement, the Base Prospectus, any Preliminary
Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by
reference therein pursuant to Item 12 of Form S-3 under the Securities Act, as of the effective
date of the Registration Statement or the date of the Base Prospectus, such Preliminary Prospectus
or the Prospectus, as the case may be, and any reference to “amend,” “amendment” or “supplement”
with respect to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be
deemed to refer to and include any documents filed after such date until the completion of the
offering of the Securities under the Securities Exchange Act of 1934, as amended, and the rules and
regulations of the Commission thereunder (collectively, the “Exchange Act”) that are deemed to be
incorporated by reference therein. For purposes of this underwriting agreement (this “Agreement”),
the term “Effective Time” means the effective date of the Registration Statement with respect to
the offering of Securities, as determined for the Company pursuant to Section 11 of the Securities
Act and Item 512 of Regulation S-K, as applicable.
At or prior to the time when sales of the Securities were first made (the “Time of Sale”), the
Company had prepared the following information (collectively, the “Time of Sale Information”): a
Preliminary Prospectus dated April 29, 2009 and each “free-writing prospectus” (as defined pursuant
to Rule 405 under the Securities Act) listed on Schedule 2 hereto as constituting part of the Time
of Sale Information.
2. Purchase of the Securities by the Underwriters. (a) The Company agrees to issue
and sell the Securities to the several Underwriters as provided in this Agreement, and each
Underwriter, on the basis of the representations, warranties and agreements set forth herein and
subject to the conditions set forth herein, agrees, severally and not jointly, to purchase from the
Company the respective principal amount of Securities set forth opposite such Underwriter’s name in
Schedule 1 hereto at a price equal to 99.201% of the principal amount thereof plus accrued
interest, if any, from May 4, 2009 to the Closing Date (as defined below). The Company will not be
obligated to
2
deliver any of the Securities except upon payment for all the Securities to be purchased as
provided herein.
(b) The Company understands that the Underwriters intend to make a public offering of
the Securities as soon after the effectiveness of this Agreement as in the judgment of the
Representatives is advisable, and initially to offer the Securities on the terms set forth
in the Time of Sale Information and the Prospectus. Schedule 2 hereto sets forth the Time
of Sale Information made available at the Time of Sale. The Company acknowledges and agrees
that the Underwriters may offer and sell Securities to or through any affiliate of an
Underwriter and that any such affiliate may offer and sell Securities purchased by it to or
through any Underwriter.
(c) Payment for and delivery of the Securities shall be made at the offices of Xxxxx
Xxxx & Xxxxxxxx, 000 Xxxxxxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000, at 10:00 A.M., New York
City time, on May 4, 2009, or at such other time or place on the same or such other date,
not later than the fifth business day thereafter, as the Representatives and the Company may
agree upon in writing. The time and date of such payment and delivery is referred to herein
as the “Closing Date.”
(d) Payment for the Securities shall be made by wire transfer in immediately available
funds to the account(s) specified by the Company to the Representatives against delivery to
the nominee of The Depository Trust Company, for the account of the Underwriters, of one or
more global notes representing the Securities (collectively, the “Global Note”), with any
transfer taxes payable in connection with the sale of the Securities duly paid by the
Company. The Global Note will be made available for inspection by the Representatives not
later than 1:00 P.M., New York City time, on the business day prior to the Closing Date.
(e) The Company acknowledges and agrees that the Underwriters are acting solely in the
capacity of an arm’s length contractual counterparty to the Company with respect to the
offering of Securities contemplated hereby (including in connection with determining the
terms of the offering) and not as a financial advisor or a fiduciary to, or an agent of, the
Company or any other person. Additionally, neither the Representatives nor any other
Underwriter is advising the Company or any other person as to any legal, tax, investment,
accounting or regulatory matters in any jurisdiction. The Company shall consult with its
own advisors concerning such matters and shall be responsible for making its own independent
investigation and appraisal of the transactions contemplated hereby, and the Underwriters
shall have no responsibility or liability to the Company with respect thereto. Any review
by the Underwriters of the Company, the transactions contemplated hereby or other matters
relating to such
3
transactions will be performed solely for the benefit of the Underwriters and shall not
be on behalf of the Company.
3. Representations and Warranties of the Company. The Company represents and warrants
to each Underwriter that:
(a) Registration Statement and Prospectus. The Registration Statement is an “automatic
shelf registration statement” as defined under Rule 405 of the Securities Act that has been
filed with the Commission not earlier than three years prior to the date hereof; and no
notice of objection of the Commission to the use of such registration statement or any
post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has
been received by the Company. No order suspending the effectiveness of the Registration
Statement has been issued by the Commission, and no proceeding for that purpose or pursuant
to Section 8A of the Securities Act against the Company or related to the offering has been
initiated or threatened by the Commission; as of the Effective Time, the Registration
Statement complied in all material respects with the Securities Act and the Trust Indenture
Act of 1939, as amended, and the rules and regulations of the Commission thereunder
(collectively, the “Trust Indenture Act”), and did not or will not contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein not misleading; and as of the date of
the Prospectus and any amendment or supplement thereto and as of the Closing Date, the
Prospectus did not and will not contain any untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not
misleading; provided that the Company makes no representation and warranty with
respect to (i) that part of the Registration Statement that constitutes the Statement of
Eligibility and Qualification (Form T-1) of the Trustee under the Trust Indenture Act or
(ii) any statements or omissions in the Registration Statement and the Prospectus and any
amendment or supplement thereto made in reliance upon and in conformity with information
relating to any Underwriter furnished to the Company in writing by such Underwriter through
the Representatives expressly for use therein.
(b) Time of Sale Information. The Time of Sale Information, at the Time of Sale did
not, and at the Closing Date will not, contain any untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading; provided that
the Company makes no representation and warranty with respect to any statements or omissions
made in reliance upon and in conformity with information relating to any Underwriter
furnished to the Company in writing by such Underwriter through the Representatives
expressly for use in such Time of Sale Information. No statement of material fact included
in the Prospectus has been omitted from the Time of Sale Information, and no
4
statement of material fact included in the Time of Sale Information that is required to
be included in the Prospectus has been omitted therefrom.
(c) Issuer Free Writing Prospectus. The Company (including its agents and
representatives, other than the Underwriters in their capacity as such) has not prepared,
made, used, authorized, approved or referred to and will not prepare, make, use, authorize,
approve or refer to any “written communication” (as defined in Rule 405 under the Securities
Act) that constitutes an offer to sell or solicitation of an offer to buy the Securities
(each such communication by the Company or its agents and representatives, other than the
Underwriters (other than a communication referred to in clauses (i), (ii) and (iii) below),
an “Issuer Free Writing Prospectus”) other than (i) any document not constituting a
prospectus pursuant to Section 2(a)(10)(a) of the Securities Act or Rule 134 under the
Securities Act, (ii) the Preliminary Prospectus, (iii) the Prospectus, (iv) the documents
listed on Schedule 2 as constituting the Time of Sale Information and (v) any electronic
road show or other written communications, in each case approved in writing in advance by
the Representatives. Each such Issuer Free Writing Prospectus complied in all material
respects with the Securities Act, has been or will be (within the time period specified in
Rule 433) filed in accordance with the Securities Act (to the extent required thereby) and,
when taken together with the Preliminary Prospectus accompanying, or delivered prior to
delivery of, or filed prior to the first use of such Issuer Free Writing Prospectus, did
not, and at the Closing Date will not, contain any untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading; provided that
the Company makes no representation and warranty with respect to any statements or omissions
made in each such Issuer Free Writing Prospectus in reliance upon and in conformity with
information relating to any Underwriter furnished to the Company in writing by such
Underwriter through the Representatives expressly for use in any Issuer Free Writing
Prospectus.
(d) Incorporated Documents. The documents incorporated by reference in the
Registration Statement, the Prospectus and the Time of Sale Information, when filed with the
Commission, conformed in all material respects with the requirements of the Exchange Act and
did not contain an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein, in the light of
the circumstances under which they were made, not misleading; and any further documents so
filed and incorporated by reference in the Registration Statement, the Prospectus or the
Time of Sale Information, when such documents become effective or are filed with the
Commission, as the case may be, will conform in all material respects with the requirements
of the Exchange Act and will not contain an untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading;
provided that the
5
Company makes no representation and warranty with respect to any statements or
omissions made in reliance upon and in conformity with information relating to any
Underwriter furnished to the Company in writing by such Underwriter through the
Representatives expressly for use therein.
(e) Financial Statements. The financial statements and the related notes thereto
included or incorporated by reference in the Registration Statement, the Time of Sale
Information and the Prospectus comply in all material respects with the applicable
requirements of the Securities Act and the Exchange Act, as applicable, and present fairly,
on a consolidated basis, the financial position of the Company and its subsidiaries as of
the dates indicated and the results of their operations and the changes in their cash flows
for the periods specified; such financial statements have been prepared in conformity with
generally accepted accounting principles applied on a consistent basis throughout the
periods covered thereby, and the supporting schedules included or incorporated by reference
in the Registration Statement present fairly the information required to be stated therein;
the other financial information included or incorporated by reference in the Registration
Statement, the Time of Sale Information and the Prospectus has been derived from the
accounting records of the Company and its subsidiaries and presents fairly the information
shown thereby; and any pro forma financial information and the related notes
thereto included or incorporated by reference in the Registration Statement, the Time of
Sale Information and the Prospectus have been prepared in accordance with the applicable
requirements of the Securities Act and the Exchange Act, as applicable, and the assumptions
underlying such pro forma financial information are reasonable and are set
forth in the Registration Statement, the Time of Sale Information and the Prospectus.
(f) No Material Adverse Change. Since the date of the most recent consolidated
financial statements of the Company and its subsidiaries included or incorporated by
reference in the Registration Statement, the Time of Sale Information and the Prospectus,
(i) there has not been any change in the capital stock or long-term debt of the Company or
its subsidiaries, on a consolidated basis, or any dividend or distribution of any kind
declared, set aside for payment, paid or made by the Company on any class of capital stock,
or any material adverse change, or any development involving a prospective material adverse
change, in or affecting the business, properties, financial condition or results of
operations of the Company and its subsidiaries taken as a whole; (ii) neither the Company
nor any of its subsidiaries has entered into any transaction or agreement that is material
to the Company and its subsidiaries taken as a whole or incurred any liability or
obligation, direct or contingent, that is material to the Company and its subsidiaries taken
as a whole; and (iii) the Company and its subsidiaries, taken as a whole, have not sustained
any material loss or interference with their business from fire, explosion, flood or other
calamity, whether or not covered by insurance, or from any labor disturbance or dispute or
6
any action, order or decree of any court or arbitrator or governmental or regulatory
authority, except in each case, with respect to each of clauses (i), (ii) and (iii) above,
as otherwise disclosed in the Registration Statement, the Time of Sale Information and the
Prospectus.
(g) Organization and Good Standing. The Company and each of its “significant
subsidiaries” (as defined in Rule 1-02 of Regulation S-X under the Exchange Act) have been
duly organized and are validly existing and in good standing under the laws of their
respective jurisdictions of organization, are duly qualified to do business and are in good
standing in each jurisdiction in which their respective ownership or lease of property or
the conduct of their respective businesses requires such qualification, and have all power
and authority necessary to own or hold their respective properties and to conduct the
businesses in which they are engaged, except where the failure to be so qualified, in good
standing or have such power or authority would not, individually or in the aggregate, have a
material adverse effect on the business, properties, financial condition or results of
operations of the Company and its subsidiaries taken as a whole or on the performance by the
Company of its obligations under the Securities (a “Material Adverse Effect”).
(h) Capitalization. The Company has an authorized capitalization as set forth in the
Registration Statement, the Time of Sale Information and the Prospectus under the heading
“Capitalization”; and all the outstanding shares of capital stock or other equity interests
of each subsidiary of the Company have been duly and validly authorized and issued, are
fully paid and non-assessable and (except, in the case of any foreign subsidiary, for
directors’ qualifying shares) are owned directly or indirectly by the Company, free and
clear of any lien, charge, encumbrance, security interest, restriction on voting or transfer
or any other claim of any third party.
(i) Due Authorization. The Company has full right, power and authority to execute and
deliver this Agreement, the Securities and the Indenture (collectively, the “Transaction
Documents”) and to perform its obligations hereunder and thereunder; and all action required
to be taken for the due and proper authorization, execution and delivery of each of the
Transaction Documents and the consummation of the transactions contemplated thereby has been
duly and validly taken.
(j) The Indenture. The Base Indenture has been duly authorized, executed and delivered
by the Company and when the Supplemental Indenture is duly executed in accordance with its
terms by each of the parties thereto, the Indenture will be duly qualified under the Trust
Indenture Act and will constitute a valid and legally binding agreement of the Company
enforceable against the Company in accordance with its terms, except as enforceability may
be limited by applicable bankruptcy, insolvency, reorganization or similar laws affecting
the
7
enforcement of creditors’ rights generally or by equitable principles relating to
enforceability (collectively, the “Enforceability Exceptions”).
(k) The Securities. The Securities have been duly authorized by the Company and, when
duly executed, authenticated, issued and delivered as provided in the Indenture and paid for
as provided herein, will be duly and validly issued and outstanding and will constitute
valid and legally binding obligations of the Company enforceable against the Company in
accordance with their terms, subject to the Enforceability Exceptions, and will be entitled
to the benefits of the Indenture.
(l) Underwriting Agreement. This Agreement has been duly authorized, executed and
delivered by the Company.
(m) Descriptions of the Transaction Documents. Each Transaction Document conforms in
all material respects to the description thereof contained in the Registration Statement,
the Time of Sale Information and the Prospectus.
(n) No Violation or Default. Neither the Company nor any of its subsidiaries is (i) in
violation of its charter or by-laws or similar organizational documents; (ii) in default,
and no event has occurred that, with notice or lapse of time or both, would constitute such
a default, in the due performance or observance of any term, covenant or condition contained
in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument
to which the Company or any of its subsidiaries is a party or by which the Company or any of
its subsidiaries is bound or to which any of the property or assets of the Company or any of
its subsidiaries is subject; or (iii) in violation of any law or statute or any judgment,
order, rule or regulation of any court or arbitrator or governmental or regulatory
authority, except, in the case of clauses (ii) and (iii) above, for any such default or
violation that would not, individually or in the aggregate, have a Material Adverse Effect.
(o) No Conflicts. The execution, delivery and performance by the Company of each of
the Transaction Documents, the issuance and sale of the Securities and compliance by the
Company with the terms thereof and the consummation of the transactions contemplated by the
Transaction Documents will not (i) conflict with or result in a breach or violation of any
of the terms or provisions of, or constitute a default under, or result in the creation or
imposition of any lien, charge or encumbrance upon any property or assets of the Company or
any of its subsidiaries pursuant to, any indenture, mortgage, deed of trust, loan agreement
or other agreement or instrument to which the Company or any of its subsidiaries is a party
or by which the Company or any of its subsidiaries is bound or to which any of the property
or assets of the Company or any of its subsidiaries is subject, (ii) result in any violation
of the provisions of the charter or by-laws or similar organizational documents of the
Company or any of its
8
subsidiaries or (iii) result in the violation of any law or statute or any judgment,
order, rule or regulation of any court or arbitrator or governmental or regulatory
authority, except, in the case of clauses (i) and (iii) above, for any such conflict,
breach, violation, default, lien, charge or encumbrance that would not, individually or in
the aggregate, have a Material Adverse Effect.
(p) No Consents Required. No consent, approval, authorization, order, registration or
qualification of or with any court or arbitrator or governmental or regulatory authority is
required for the execution, delivery and performance by the Company of each of the
Transaction Documents, the issuance and sale of the Securities and compliance by the Company
with the terms thereof and the consummation of the transactions contemplated by the
Transaction Documents, except for such consents, approvals, authorizations, orders and
registrations or qualifications (i) as have been or will be obtained under the Securities
Act and the Trust Indenture Act and (ii) as may be required under applicable state
securities laws in connection with the purchase and distribution of the Securities by the
Underwriters.
(q) Legal Proceedings. Except as described in the Registration Statement, the Time of
Sale Information and the Prospectus, there are no legal, governmental or regulatory
investigations, actions, suits or proceedings pending to which the Company or any of its
subsidiaries is or may be a party or to which any property of the Company or any of its
subsidiaries is or may be the subject that, individually or in the aggregate, if determined
adversely to the Company or any of its subsidiaries, could reasonably be expected to have a
Material Adverse Effect; no such investigations, actions, suits or proceedings are
threatened or, to the best knowledge of the Company, contemplated by any governmental or
regulatory authority or threatened by others; and (i) there are no current or pending legal,
governmental or regulatory actions, suits or proceedings that are required under the
Securities Act to be described in the Registration Statement or the Prospectus that are not
so described in the Registration Statement, the Time of Sale Information and the Prospectus
and (ii) there are no contracts or other documents that are required under the Securities
Act to be filed as exhibits to the Registration Statement and described in the Registration
Statement or the Prospectus that are not so filed as exhibits to the Registration Statement
or described in the Registration Statement, the Time of Sale Information and the Prospectus.
(r) Independent Accountants. Deloitte & Touche LLP, who has certified certain
financial statements of the Company and its subsidiaries, is an independent registered
public accounting firm with respect to the Company and its subsidiaries within the
applicable rules and regulations adopted by the Commission and the Public Company Accounting
Oversight Board (United States) and as required by the Securities Act.
9
(s) Investment Company Act. The Company is not and, after giving effect to the
offering and sale of the Securities and the application of the proceeds thereof as described
in the Registration Statement, the Time of Sale Information and the Prospectus, will not be
an “investment company” within the meaning of the Investment Company Act of 1940, as
amended, and the rules and regulations of the Commission thereunder (collectively, the
“Investment Company Act”).
(t) Forward-Looking Statements. No forward-looking statement (within the meaning of
Section 27A of the Securities Act and Section 21E of the Exchange Act) contained or
incorporated by reference in the Registration Statement, the Time of Sale Information and
the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed
other than in good faith.
(u) Status under the Securities Act. The Company is not an ineligible issuer and is a
well-known seasoned issuer, in each case as defined in Rule 405 under the Securities Act, in
each case at the times specified in the Securities Act in connection with the offering of
the Securities.
(v) Title to Real and Personal Property. The Company and its subsidiaries have good
and marketable title in fee simple to, or have valid rights to lease or otherwise use, all
items of real and personal property that are material to the respective businesses of the
Company and its subsidiaries, in each case free and clear of all liens, encumbrances, claims
and defects and imperfections of title except such as are described in the Registration
Statement, the Time of Sale Information and the Prospectus and except those that (i) do not
materially interfere with the use made and proposed to be made of such property by the
Company and its subsidiaries or (ii) could not reasonably be expected, individually or in
the aggregate, to have a Material Adverse Effect.
(w) Title to Intellectual Property. The Company and its subsidiaries own or possess or
can acquire on reasonable terms adequate rights to use all material patents, patent
applications, trademarks, service marks, trade names, trademark registrations, service xxxx
registrations, copyrights, licenses and know-how (including trade secrets and other
unpatented and/or unpatentable proprietary or confidential information, systems or
procedures) necessary for the conduct of their respective businesses now operated by them;
and the Company and its subsidiaries have not received any notice of any claim of
infringement or conflict with any such rights of others that, if determined adversely to the
Company or any of its subsidiaries, could reasonably be expected to have a Material Adverse
Effect.
(x) Taxes. The Company and its subsidiaries have paid all federal, state, local and
foreign taxes and filed all tax returns required to be paid or filed through the date
hereof; and except as would not have a Material Adverse Effect or as otherwise disclosed in
the Registration Statement, the Time of Sale
10
Information and the Prospectus, there is no tax deficiency that has been, or could
reasonably be expected to be, asserted against the Company or any of its subsidiaries or any
of their respective properties or assets.
(y) Licenses and Permits. The Company and its subsidiaries possess all licenses,
certificates, permits and other authorizations issued by, and have made all declarations and
filings with, the appropriate federal, state, local or foreign governmental or regulatory
authorities that are necessary for the ownership or lease of their respective properties or
the conduct of their respective businesses as described in the Registration Statement, the
Time of Sale Information and the Prospectus, except where the failure to possess or make the
same would not, individually or in the aggregate, have a Material Adverse Effect; and except
as described in the Registration Statement, the Time of Sale Information and the Prospectus,
neither the Company nor any of its subsidiaries has received notice of any revocation or
modification of any such license, certificate, permit or authorization or has any reason to
believe that any such license, certificate, permit or authorization will not be renewed in
the ordinary course.
(z) No Labor Disputes. No labor disturbance by or dispute with employees of the
Company or any of its subsidiaries exists or, to the best knowledge of the Company, is
contemplated or threatened, and the Company is not aware of any existing or imminent labor
disturbance by, or dispute with, the employees of any of its or its subsidiaries’ principal
suppliers, contractors or customers, except in each case as would not have a Material
Adverse Effect.
(aa) Compliance With Environmental Laws. (i) Except with respect to any matters that,
individually or in the aggregate, would not result in a Material Adverse Effect, the Company
and its subsidiaries (x) are, and at all prior times were, in compliance with any and all
applicable federal, state, local and foreign laws, rules, regulations, requirements,
decisions and orders relating to the protection of human health or safety, the environment,
natural resources, hazardous or toxic substances or wastes, pollutants or contaminants
(collectively, “Environmental Laws”); (y) have received and are in compliance with all
permits, licenses, certificates or other authorizations or approvals required of them under
applicable Environmental Laws to conduct their respective businesses; and (z) have not
received notice of any actual or potential liability under or relating to any Environmental
Laws, including for the investigation or remediation of any disposal or release of hazardous
or toxic substances or wastes, pollutants or contaminants and have no knowledge of any event
or condition that would reasonably be expected to result in any such notice; (ii) there are
no costs or liabilities associated with Environmental Laws of or relating to the Company or
its subsidiaries, except for (x) costs or liabilities associated with failure to receive or
comply with required permits, licenses or approvals or (y) other costs or liabilities
associated with Environmental Laws,
11
where, in either case of (x) or (y), such costs or liabilities would not, individually
or in the aggregate, have a Material Adverse Effect and (iii) except as described in the
Time of Sale Information and the Prospectus, (x) there are no proceedings that are pending,
or that are known to be contemplated, against the Company or any of its subsidiaries under
any Environmental Laws in which a governmental entity is also a party, other than such
proceedings regarding which it is reasonably believed no monetary sanctions of $100,000 or
more will be imposed, (y) the Company and its subsidiaries are not aware of any issues
regarding compliance with Environmental Laws, or liabilities or other obligations under
Environmental Laws or concerning hazardous or toxic substances or wastes, pollutants or
contaminants, that could reasonably be expected to have a material effect on the capital
expenditures, earnings or competitive position of the Company and its subsidiaries, and (z)
none of the Company and its subsidiaries anticipates material capital expenditures during
2009 relating to any Environmental Laws.
(bb) Disclosure Controls. The Company maintains “disclosure controls and procedures”
(as defined in Rule 13a-15(e) of the Exchange Act) that are effective in all material
respects in providing reasonable assurance that information required to be disclosed by the
Company in reports that it files or submits under the Exchange Act is recorded, processed,
summarized and reported within the time periods specified in the Commission’s rules and
forms, including controls and procedures designed to ensure that such information is
accumulated and communicated to the Company’s management as appropriate to allow timely
decisions regarding required disclosure. The Company has carried out evaluations of the
effectiveness of such disclosure controls and procedures as required by Rule 13a-15 of the
Exchange Act.
(cc) Accounting Controls. The Company maintains a system of “internal control over
financial reporting” (as defined in Rule 13a-15(f) of the Exchange Act) that complies with
the requirements of the Exchange Act and has been designed by, or under the supervision of
its principal executive and principal financial officers, or persons performing similar
functions, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles, including, but not limited to internal accounting
controls sufficient to provide reasonable assurance that (i) transactions are executed in
accordance with management’s general or specific authorizations; (ii) transactions are
recorded as necessary to permit preparation of financial statements in conformity with
generally accepted accounting principles and to maintain asset accountability; (iii) access
to assets is permitted only in accordance with management’s general or specific
authorization; and (iv) the recorded accountability for assets is compared with the existing
assets at reasonable intervals and appropriate action is taken with respect to any
differences. Except as disclosed in the Registration Statement, the Time of Sale
12
Information and the Prospectus, there are no material weaknesses in the Company’s
internal controls.
(dd) Insurance. Except as disclosed in the Registration Statement, the Time of Sale
Information and the Prospectus, the Company and its subsidiaries have insurance covering
such risks as are customarily carried by businesses similarly situated, which insurance is
in amounts and insures against such losses and risks as are generally deemed adequate and
customary for their businesses; and neither the Company nor any of its subsidiaries has (i)
received notice from any insurer or agent of such insurer that capital improvements or other
expenditures are required or necessary to be made in order to continue such insurance or
(ii) any reason to believe that it will not be able to renew its existing insurance coverage
as and when such coverage expires or to obtain similar coverage at a cost that would not
have a Material Adverse Effect from similar insurers as may be necessary to continue its
business.
(ee) Compliance with Money Laundering Laws. The operations of the Company and its
subsidiaries are and have been conducted at all times in compliance with applicable
financial recordkeeping and reporting requirements of the Currency and Foreign Transactions
Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the
rules and regulations thereunder and any related or similar rules, regulations or
guidelines, issued, administered or enforced by any governmental agency (collectively, the
“Money Laundering Laws”) and no action, suit or proceeding by or before any court or
governmental agency, authority or body or any arbitrator involving the Company or any of its
subsidiaries with respect to the Money Laundering Laws is pending or, to the best knowledge
of the Company, threatened.
(ff) Compliance with OFAC. None of the Company, any of its subsidiaries or, to the
knowledge of the Company, any director, officer, agent, employee or Affiliate of the Company
or any of its subsidiaries is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”); and the
Company will not directly or indirectly use the proceeds of the offering of the Securities
hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary,
joint venture partner or other person or entity, for the purpose of financing the activities
of any person currently subject to any U.S. sanctions administered by OFAC.
(gg) No Unlawful Payments. Neither the Company nor any of its subsidiaries nor, to the
best knowledge of the Company, any director, officer, agent, employee or other person
associated with or acting on behalf of the Company or any of its subsidiaries has (i) used
any corporate funds for any unlawful contribution, gift, entertainment or other unlawful
expense relating to political activity; (ii) made any direct or indirect unlawful payment to
any foreign or domestic
13
government official or employee from corporate funds; (iii) violated or is in violation
of any provision of the Foreign Corrupt Practices Act of 1977; or (iv) made any bribe,
rebate, payoff, influence payment, kickback or other unlawful payment.
(hh) Margin Rules. Neither the issuance, sale and delivery of the Securities nor the
application of the proceeds thereof by the Company as described in the Registration
Statement, the Time of Sale Information and the Prospectus will violate Regulation T, U or X
of the Board of Governors of the Federal Reserve System or any other regulation of such
Board of Governors promulgated thereunder.
(ii) No Stabilization. The Company has not taken, directly or indirectly, any action
designed to or that could reasonably be expected to cause or result in any stabilization or
manipulation of the price of the Securities.
(jj) Business With Cuba. The Company has complied with all provisions of Section
517.075, Florida Statutes (Chapter 92-198, Laws of Florida), relating to doing business with
the Government of Cuba or with any person or affiliate located in Cuba.
(kk) Statistical and Market Data. Nothing has come to the attention of the Company
that has caused the Company to believe that the statistical and market-related data included
or incorporated by reference in the Registration Statement, the Time of Sale Information and
the Prospectus is not based on or derived from sources that are reliable and accurate in all
material respects.
(ll) Xxxxxxxx-Xxxxx Act. There is and has been no failure on the part of the Company
or any of the Company’s directors or officers, in their capacities as such, to comply with
any provision of the Xxxxxxxx-Xxxxx Act of 2002 and the rules and regulations promulgated in
connection therewith (the “Xxxxxxxx-Xxxxx Act”), including Section 402 related to loans and
Sections 302 and 906 related to certifications, except where such failure to comply would
not, individually or in the aggregate, have a Material Adverse Effect.
4. Further Agreements of the Company. The Company covenants and agrees with each
Underwriter that:
(a) Filings with the Commission. The Company will (i) pay the registration fees for
this offering within the time period required by Rule 456(b)1(i) under the Securities Act
(without giving effect to the proviso therein) and in any event prior to the Closing Date
and (ii) file the Prospectus in a form approved by the Representatives with the Commission
pursuant to Rule 424 under the Securities Act not later than the close of business on the
second business day following the date of determination of the public offering price of the
Securities or,
if applicable, such earlier time as may be required by Rule 424(b) and Rule
14
430A, 430B
or 430C under the Securities Act. The Company will file any Issuer Free Writing Prospectus
(including the Term Sheet in the form of Schedule 3) to the extent required by Rule 433
under the Securities Act; and the Company will furnish copies of the Prospectus and each
Issuer Free Writing Prospectus (to the extent not previously delivered) to the Underwriters
in New York City prior to 10:00 A.M., New York City time, on the business day next
succeeding the date of this Agreement in such quantities as the Representatives may
reasonably request.
(b) Delivery of Copies. The Company will deliver, without charge, to each Underwriter
during the Prospectus Delivery Period (as defined below), as many copies of the Prospectus
(including all amendments and supplements thereto) and each Issuer Free Writing Prospectus
(if applicable) as the Representatives may reasonably request. As used herein, the term
“Prospectus Delivery Period” means such period of time after the first date of the public
offering of the Securities as in the opinion of counsel for the Underwriters a prospectus
relating to the Securities is required by law to be delivered (or required to be delivered
but for Rule 172 under the Securities Act) in connection with sales of the Securities by any
Underwriter or dealer.
(c) Amendments or Supplements; Issuer Free Writing Prospectuses. Prior to termination
of the offering of the Securities, before making, preparing, using, authorizing, approving,
referring to or filing any Issuer Free Writing Prospectus, and before filing any amendment
or supplement to the Registration Statement or the Prospectus, the Company will furnish to
the Representatives and counsel for the Underwriters a copy of the proposed Issuer Free
Writing Prospectus, amendment or supplement for review and will not make, prepare, use,
authorize, approve, refer to or file any such Issuer Free Writing Prospectus or file any
such proposed amendment or supplement to which the Representatives reasonably object.
(d) Notice to the Representatives. The Company will advise the Representatives
promptly, and confirm such advice in writing, (i) when, prior to termination of the offering
of the Securities, any amendment to the Registration Statement has been filed or becomes
effective; (ii) when, prior to termination of the offering of the Securities, any supplement
to the Prospectus or any amendment to the Prospectus or any Issuer Free Writing Prospectus
has been filed; (iii) of any request by the Commission for any amendment to the Registration
Statement or any amendment or supplement to the Prospectus or the receipt of any comments
from the Commission relating to the Registration Statement or any other request by the
Commission for any additional information; (iv) when it learns of the issuance by the
Commission of any order suspending the effectiveness of the Registration Statement or
preventing or suspending the use of any Preliminary Prospectus or the Prospectus or the
initiation or
threatening of any proceeding for that purpose or pursuant to Section 8A of the
15
Securities Act; (v) when it learns of the occurrence of any event within the Prospectus
Delivery Period as a result of which the Prospectus, the Time of Sale Information or any
Issuer Free Writing Prospectus as then amended or supplemented would include any untrue
statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances
existing when the Prospectus, the Time of Sale Information or any such Issuer Free Writing
Prospectus is delivered to a purchaser, not misleading; (vi) of the receipt by the Company
of any notice of objection of the Commission to the use of the Registration Statement or any
post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act and
(vii) of the receipt by the Company of any notice with respect to any suspension of the
qualification of the Securities for offer and sale in any jurisdiction or the initiation or
threatening of any proceeding for such purpose; and the Company will use its reasonable best
efforts to prevent the issuance of any such order suspending the effectiveness of the
Registration Statement, preventing or suspending the use of any Preliminary Prospectus or
the Prospectus or suspending any such qualification of the Securities and, if any such order
is issued, will obtain as soon as possible the withdrawal thereof.
(e) Time of Sale Information. If at any time prior to the Closing Date (i) any event
shall occur or condition shall exist as a result of which the Time of Sale Information as
then amended or supplemented would include any untrue statement of a material fact or omit
to state any material fact necessary in order to make the statements therein, in the light
of the circumstances, not misleading or (ii) it is necessary to amend or supplement the Time
of Sale Information to comply with law, the Company will promptly notify the Underwriters
thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission
(to the extent required) and furnish to the Underwriters and to such dealers as the
Representatives may designate, such amendments or supplements to the Time of Sale
Information as may be necessary so that the statements in the Time of Sale Information as so
amended or supplemented will not, in the light of the circumstances, be misleading or so
that the Time of Sale Information will comply with law.
(f) Ongoing Compliance. If during the Prospectus Delivery Period (i) any event shall
occur or condition shall exist as a result of which the Prospectus as then amended or
supplemented would include any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances existing when the Prospectus is delivered to a
purchaser, not misleading or (ii) it is necessary to amend or supplement the Prospectus to
comply with law, the Company will promptly notify the Underwriters thereof and forthwith
prepare and, subject to paragraph (c) above, file with the Commission and furnish to the
Underwriters and to such dealers as the Representatives may
designate, such amendments or supplements to the Prospectus as may be
16
necessary so that
the statements in the Prospectus as so amended or supplemented will not, in the light of the
circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so
that the Prospectus will comply with law.
(g) Blue Sky Compliance. The Company will qualify the Securities for offer and sale
under the securities or Blue Sky laws of such jurisdictions as the Representatives shall
reasonably request and will continue such qualifications in effect so long as required for
distribution of the Securities; provided that the Company shall not be required to
(i) qualify as a foreign corporation or other entity or as a dealer in securities in any
such jurisdiction where it would not otherwise be required to so qualify, (ii) file any
general consent to service of process in any such jurisdiction or (iii) subject itself to
taxation in any such jurisdiction if it is not otherwise so subject.
(h) Earning Statement. The Company will make generally available to its security
holders and the Representatives as soon as practicable an earning statement that satisfies
the provisions of Section 11(a) of the Securities Act and Rule 158 of the Commission
promulgated thereunder covering a period of at least twelve months beginning with the first
fiscal quarter of the Company occurring after the “effective date” (as defined in Rule 158)
of the Registration Statement.
(i) Clear Market. During the period from the date hereof through and including the
Closing Date, the Company will not, without the prior written consent of the
Representatives, offer, sell, contract to sell or otherwise dispose of any debt securities
issued or guaranteed by the Company and having a tenor of more than one year.
(j) Use of Proceeds. The Company will apply the net proceeds from the sale of the
Securities as described in the Registration Statement, the Time of Sale Information and the
Prospectus under the heading “Use of proceeds.”
(k) No Stabilization. The Company will not take, directly or indirectly, any action
designed to or that could reasonably be expected to cause or result in any stabilization or
manipulation of the price of the Securities.
(l) Filing of Exchange Act Documents. The Company will file promptly all reports and
any definitive proxy or information statements required to be filed by the Company with the
Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act during the
Prospectus Delivery Period.
(m) Record Retention. The Company will, pursuant to reasonable procedures developed in
good faith, retain copies of each Issuer Free Writing
17
Prospectus that is not filed with the Commission in accordance with Rule 433 under the
Securities Act.
5. Certain Agreements of the Underwriters. Each Underwriter hereby represents and
agrees that:
(a) It has not and will not use, authorize use of, refer to, or participate in the
planning for use of, any “free writing prospectus,” as defined in Rule 405 under the
Securities Act (which term includes use of any written information furnished to the
Commission by the Company and not incorporated by reference into the Registration Statement
and any press release issued by the Company) other than (i) a free writing prospectus that,
solely a result of use by such Underwriter, would not trigger an obligation to file such
free writing prospectus with the Commission pursuant to Rule 433, (ii) any Issuer Free
Writing Prospectus listed on Schedule 2 or prepared pursuant to Section 3(c) or Section 4(c)
above (including any electronic road show if the contents therein have been prepared by, or
approved in advance by, the Company), or (iii) any free writing prospectus prepared by such
underwriter and approved by the Company in advance in writing (each such free writing
prospectus referred to in clauses (i) or (iii), an “Underwriter Free Writing Prospectus”).
(b) Notwithstanding the foregoing the Underwriters may use a term sheet substantially
in the form of Schedule 3 without the consent of the Company.
(c) It is not subject to any pending proceeding under Section 8A of the Securities Act
with respect to the offering (and will promptly notify the Company if any such proceeding
against it is initiated during the Prospectus Delivery Period).
6. Conditions of Underwriters’ Obligations. The obligation of each Underwriter to
purchase Securities on the Closing Date as provided herein is subject to the performance by the
Company of its covenants and other obligations hereunder and to the following additional
conditions:
(a) Registration Compliance; No Stop Order. If a post-effective amendment to the
Registration Statement is required to be filed under the Securities Act, such post-effective
amendment shall have become effective, and the Representatives shall have received notice
thereof, not later than 5:00 P.M., New York City time, on the date hereof; if applicable,
the Rule 462(b) Registration Statement shall have become effective by 10:00 A.M. New York
City time on the business day following the date hereof; no order suspending the
effectiveness of the Registration Statement shall be in effect, and no proceeding for such
purpose, pursuant to Rule 401(g)(2) or pursuant to Section 8A under the Securities Act shall
be pending before or threatened by the Commission; the Prospectus and each Issuer Free
Writing Prospectus shall have been timely filed
18
with the Commission under the Securities Act (in the case of an Issuer Free Writing
Prospectus, to the extent required by Rule 433 under the Securities Act) and in accordance
with Section 4(a) hereof; and all requests by the Commission for additional information
shall have been complied with to the reasonable satisfaction of the Representatives.
(b) Representations and Warranties. The representations and warranties of the Company
contained herein shall be true and correct on the date hereof and on and as of the Closing
Date; and the statements of the Company and its officers made in any certificates delivered
pursuant to this Agreement shall be true and correct on and as of the Closing Date.
(c) No Downgrade. Subsequent to the earlier of (A) the Time of Sale and (B) the
execution and delivery of this Agreement, (i) no downgrading shall have occurred in the
rating accorded the Securities or any other debt securities or preferred stock of or
guaranteed by the Company or any of its subsidiaries by any “nationally recognized
statistical rating organization,” as such term is defined by the Commission for purposes of
Rule 436(g)(2) under the Securities Act and (ii) no such organization shall have publicly
announced that it has under surveillance or review, or has changed its outlook with respect
to, its rating of the Securities or of any other debt securities or preferred stock of or
guaranteed by the Company or any of its subsidiaries (other than an announcement with
positive implications of a possible upgrading).
(d) No Material Adverse Change. No event or condition of a type described in Section
3(f) hereof shall have occurred or shall exist, which event or condition is not described in
the Time of Sale Information (excluding any amendment or supplement thereto) and the
Prospectus (excluding any amendment or supplement thereto) and the effect of which in the
judgment of the Representatives makes it impracticable or inadvisable to proceed with the
offering, sale or delivery of the Securities on the terms and in the manner contemplated by
this Agreement, the Time of Sale Information and the Prospectus.
(e) Officer’s Certificate. The Representatives shall have received on and as of the
Closing Date a certificate of an executive officer of the Company who has specific knowledge
of the Company’s financial matters and is satisfactory to the Representatives (i) confirming
that such officer has carefully reviewed the Registration Statement, the Time of Sale
Information and the Prospectus and, to the best knowledge of such officer, the
representations set forth in Sections 3(a) and 3(b) hereof are true and correct, (ii)
confirming that the other representations and warranties of the Company in this Agreement
are true and correct and that the Company has complied with all agreements and satisfied all
conditions on its part to be performed or satisfied hereunder at or
19
prior to the Closing Date and (iii) to the effect set forth in paragraphs 6(a), 6(c)
and 6(d).
(f) Comfort Letters. On the date of this Agreement and on the Closing Date, Deloitte &
Touche LLP shall have furnished to the Representatives, at the request of the Company,
letters, dated the respective dates of delivery thereof and addressed to the Underwriters,
in form and substance reasonably satisfactory to the Representatives, containing statements
and information of the type customarily included in accountants’ “comfort letters” to
underwriters with respect to the financial statements and certain financial information
contained or incorporated by reference in the Registration Statement, the Time of Sale
Information and the Prospectus; provided that the letter delivered on the Closing
Date shall use a “cut-off” date no more than three business days prior to the Closing Date.
(g) Opinion and 10b-5 Statement of Counsel for the Company. Xxxxx Xxxxxx LLP, counsel
for the Company, shall have furnished to the Representatives, at the request of the Company,
its written opinion and 10b-5 Statement, dated the Closing Date and addressed to the
Underwriters, in form and substance reasonably satisfactory to the Representatives, to the
effect set forth in Annex A and Annex B hereto, respectively.
(h) Opinion of General Counsel for the Company. Xxxxxxx X. Xxxx, Esq., Senior Vice
President, General Counsel and Secretary of the Company, shall have furnished to the
Representatives, at the request of the Company, his written opinion, dated the Closing Date
and addressed to the Underwriters, in form and substance reasonably satisfactory to the
Representatives, to the effect set forth in Annex C hereto.
(i) Opinion and 10b-5 Statement of Counsel for the Underwriters. The Representatives
shall have received on and as of the Closing Date an opinion and 00x-0 Xxxxxxxxx xx Xxxxx
Xxxx & Xxxxxxxx, counsel for the Underwriters, with respect to such matters as the
Representatives may reasonably request, and such counsel shall have received such documents
and information as they may reasonably request to enable them to pass upon such matters.
(j) No Legal Impediment to Issuance. No action shall have been taken and no statute,
rule, regulation or order shall have been enacted, adopted or issued by any federal, state
or foreign governmental or regulatory authority that would, as of the Closing Date, prevent
the issuance or sale of the Securities; and no injunction or order of any federal, state or
foreign court shall have been issued that would, as of the Closing Date, prevent the
issuance or sale of the Securities.
(k) Good Standing. The Representatives shall have received on and as of the Closing
Date satisfactory evidence of the good standing of the
20
Company and its significant subsidiaries listed on Schedule 4 in their respective
jurisdictions of organization, in each case in writing or any standard form of
telecommunication from the appropriate governmental authorities of such jurisdictions.
(l) Additional Documents. On or prior to the Closing Date, the Company shall have
furnished to the Representatives such further certificates and documents as the
Representatives may reasonably request.
All opinions, letters, certificates and evidence mentioned above or elsewhere in this
Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form
and substance reasonably satisfactory to counsel for the Underwriters.
7. Indemnification and Contribution.
(a) Indemnification of the Underwriters. The Company agrees to indemnify and hold
harmless each Underwriter, its affiliates, directors and officers and each person, if any,
who controls such Underwriter within the meaning of Section 15 of the Securities Act or
Section 20 of the Exchange Act, from and against any and all losses, claims, damages and
liabilities (including, without limitation, legal fees and other expenses incurred in
connection with any suit, action or proceeding or any claim asserted as such fees and
expenses are incurred), joint or several, that arise out of, or are based upon, (i) any
untrue statement or alleged untrue statement of a material fact contained in the
Registration Statement, or caused by any omission or alleged omission to state therein a
material fact required to be stated therein or necessary in order to make the statements
therein, not misleading, or (ii) any untrue statement or alleged untrue statement of a
material fact contained in the Prospectus (or any amendment or supplement thereto), any
Issuer Free Writing Prospectus or any Time of Sale Information, or caused by any omission or
alleged omission to state therein a material fact necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading, in each
case in each of clauses (i) and (ii) except insofar as such losses, claims, damages or
liabilities arise out of, or are based upon, any untrue statement or omission or alleged
untrue statement or omission made in reliance upon and in conformity with any information
relating to any Underwriter furnished to the Company in writing by such Underwriter through
the Representatives expressly for use therein.
(b) Indemnification of the Company. Each Underwriter agrees, severally and not
jointly, to indemnify and hold harmless the Company, its directors, its officers who signed
the Registration Statement and each person, if any, who controls the Company within the
meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act to the same
extent as the indemnity set forth in paragraph (a) above, but only with respect to any
losses,
21
claims, damages or liabilities that arise out of, or are based upon, any untrue
statement or omission or alleged untrue statement or omission made in reliance upon and in
conformity with any information relating to such Underwriter furnished to the Company in
writing by such Underwriter through the Representatives expressly for use in the
Registration Statement, the Prospectus (or any amendment or supplement thereto), any Issuer
Free Writing Prospectus or any Time of Sale Information, it being understood and agreed that
the only such information consists of the following: the third and sixth paragraphs under
the caption “Underwriting” in the Prospectus Supplement.
(c) Notice and Procedures. If any suit, action, proceeding (including any governmental
or regulatory investigation), claim or demand shall be brought or asserted against any
person in respect of which indemnification may be sought pursuant to either paragraph (a) or
(b) above, such person (the “Indemnified Person”) shall promptly notify the person against
whom such indemnification may be sought (the “Indemnifying Person”) in writing;
provided that the failure to notify the Indemnifying Person shall not relieve it
from any liability that it may have under this Section 7 except to the extent that it has
been materially prejudiced (through the forfeiture of substantive rights or defenses) by
such failure; and provided, further, that the failure to notify the
Indemnifying Person shall not relieve it from any liability that it may have to an
Indemnified Person otherwise than under this Section 7. If any such proceeding shall be
brought or asserted against an Indemnified Person and it shall have notified the
Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably
satisfactory to the Indemnified Person (who shall not, without the consent of the
Indemnified Person, be counsel to the Indemnifying Person) to represent the Indemnified
Person and any others entitled to indemnification pursuant to this Section 7 that the
Indemnifying Person may designate in such proceeding and shall pay the fees and expenses of
such proceeding and shall pay the reasonable fees and expenses of counsel related to such
proceeding as incurred. In any such proceeding, any Indemnified Person shall have the right
to retain its own counsel, but the fees and expenses of such counsel shall be at the expense
of such Indemnified Person unless (i) the Indemnifying Person and the Indemnified Person
shall have mutually agreed to the contrary, (ii) the Indemnifying Person has failed within a
reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii)
the Indemnified Person shall have reasonably concluded that there may be legal defenses
available to it that are different from or in addition to those available to the
Indemnifying Person; or (iv) the named parties in any such proceeding (including any
impleaded parties) include both the Indemnifying Person and the Indemnified Person, and
representation of both parties by the same counsel would be inappropriate due to actual or
potential differing interests between them. Notwithstanding the foregoing, it is understood
and agreed that the Indemnifying Person shall not, in connection with any proceeding or
related proceeding in the same jurisdiction, be liable for the fees and expenses of more
than one separate firm (in addition to any local counsel)
22
for all Indemnified Persons, and that all such fees and expenses shall be reimbursed as
they are incurred. Any such separate firm for any Underwriter, its affiliates, directors
and officers and any control persons of such Underwriter shall be designated in writing by
the Representatives and any such separate firm for the Company, its directors, its officers
who signed the Registration Statement and any control persons of the Company shall be
designated in writing by the Company. The Indemnifying Person shall not be liable for any
settlement of any proceeding effected without its written consent, but if settled with such
consent or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to
indemnify each Indemnified Person from and against any loss or liability by reason of such
settlement or judgment. Notwithstanding the foregoing sentence, if at any time an
Indemnified Person shall have requested that an Indemnifying Person reimburse the
Indemnified Person for fees and expenses of counsel as contemplated by this paragraph, the
Indemnifying Person shall be liable for any settlement of any proceeding effected without
its written consent if (i) such settlement is entered into more than 30 days after receipt
by the Indemnifying Person of such request, (ii) such settlement does not include any
statement as to or any admission of fault, culpability or failure to act by or on behalf of
the Indemnifying Person and (iii) the Indemnifying Person shall not have reimbursed the
Indemnified Person in accordance with such request prior to the date of such settlement. No
Indemnifying Person shall, without the written consent of the Indemnified Person, effect any
settlement of any pending or threatened proceeding in respect of which any Indemnified
Person is or could have been a party and indemnification could have been sought hereunder by
such Indemnified Person, unless such settlement (x) includes an unconditional release of
such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified
Person, from all liability on claims that are the subject matter of such proceeding and (y)
does not include any statement as to or any admission of fault, culpability or a failure to
act by or on behalf of any Indemnified Person.
(d) Contribution. If the indemnification provided for in paragraphs (a) and (b) above
is unavailable to an Indemnified Person or insufficient in respect of any losses, claims,
damages or liabilities referred to therein, then each Indemnifying Person under such
paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to
the amount paid or payable by such Indemnified Person as a result of such losses, claims,
damages or liabilities (i) in such proportion as is appropriate to reflect the relative
benefits received by the Company on the one hand and the Underwriters on the other from the
offering of the Securities or (ii) if the allocation provided by clause (i) is not permitted
by applicable law, in such proportion as is appropriate to reflect not only the relative
benefits referred to in clause (i) but also the relative fault of the Company on the one
hand and the Underwriters on the other in connection with the statements or omissions that
resulted in such losses, claims, damages or liabilities, as well as any other relevant
equitable considerations. The relative benefits received by the Company on the one hand and
the Underwriters on the
23
other shall be deemed to be in the same respective proportions as the net proceeds
(before deducting expenses) received by the Company from the sale of the Securities and the
total underwriting discounts and commissions received by the Underwriters in connection
therewith, in each case as set forth in the table on the cover of the Prospectus, bear to
the aggregate offering price of the Securities. The relative fault of the Company on the
one hand and the Underwriters on the other shall be determined by reference to, among other
things, whether the untrue or alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact relates to information supplied by the Company or
by the Underwriters and the parties’ relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission.
(e) Limitation on Liability. The Company and the Underwriters agree that it would not
be just and equitable if contribution pursuant to this Section 7 were determined by
pro rata allocation (even if the Underwriters were treated as one entity for
such purpose) or by any other method of allocation that does not take account of the
equitable considerations referred to in paragraph (d) above. The amount paid or payable by
an Indemnified Person as a result of the losses, claims, damages and liabilities referred to
in paragraph (d) above shall be deemed to include, subject to the limitations set forth
above, any legal or other expenses incurred by such Indemnified Person in connection with
any such action or claim. Notwithstanding the provisions of this Section 7, in no event
shall an Underwriter be required to contribute any amount in excess of the amount by which
the total underwriting discounts and commissions received by such Underwriter with respect
to the offering of the Securities exceeds the amount of any damages that such Underwriter
has otherwise been required to pay by reason of such untrue or alleged untrue statement or
omission or alleged omission. No person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any
person who was not guilty of such fraudulent misrepresentation. The Underwriters’
obligations to contribute pursuant to this Section 7 are several in proportion to their
respective purchase obligations hereunder and not joint.
(f) Non-Exclusive Remedies. The remedies provided for in this Section 7 are not
exclusive and shall not limit any rights or remedies which may otherwise be available to any
Indemnified Person at law or in equity.
8. Effectiveness of Agreement. This Agreement shall become effective upon the
execution and delivery hereof by the parties hereto.
9. Termination. This Agreement may be terminated in the absolute discretion of the
Representatives, by notice to the Company prior to delivery of and payment for the Securities, if
after the execution and delivery of this Agreement and prior to the Closing Date (a) trading
generally shall have been suspended or materially limited on
24
the New York Stock Exchange or the over-the-counter market; (b) trading of any securities
issued or guaranteed by the Company shall have been suspended on any exchange or in any
over-the-counter market; (c) a general moratorium on commercial banking activities shall have been
declared by federal or New York State authorities; or (d) there shall have occurred any outbreak or
escalation of hostilities or any change in financial, political or economic conditions or any
calamity or crisis, either within or outside the United States, that, in the judgment of the
Representatives, is material and adverse and makes it impracticable or inadvisable to proceed with
the offering, sale or delivery of the Securities on the terms and in the manner contemplated by
this Agreement, the Time of Sale Information and the Prospectus.
10. Defaulting Underwriter. (a) If, on the Closing Date, any Underwriter defaults on
its obligation to purchase the Securities that it has agreed to purchase hereunder, the
non-defaulting Underwriters may in their discretion arrange for the purchase of such Securities by
other persons satisfactory to the Company on the terms contained in this Agreement. If, within 36
hours after any such default by any Underwriter, the non-defaulting Underwriters do not arrange for
the purchase of such Securities, then the Company shall be entitled to a further period of 36 hours
within which to procure other persons reasonably satisfactory to the non-defaulting Underwriters to
purchase such Securities on such terms. If other persons become obligated or agree to purchase the
Securities of a defaulting Underwriter, either the non-defaulting Underwriters or the Company may
postpone the Closing Date for up to five full business days in order to effect any changes that in
the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the
Registration Statement and the Prospectus or in any other document or arrangement, and the Company
agrees to promptly prepare any amendment or supplement to the Registration Statement and the
Prospectus that effects any such changes. As used in this Agreement, the term “Underwriter”
includes, for all purposes of this Agreement unless the context otherwise requires, any person not
listed in Schedule 1 hereto that, pursuant to this Section 10, purchases Securities that a
defaulting Underwriter agreed but failed to purchase.
(b) If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as
provided in paragraph (a) above, the aggregate principal amount of such Securities that
remains unpurchased does not exceed one-eleventh of the aggregate principal amount of all
the Securities, then the Company shall have the right to require each non-defaulting
Underwriter to purchase the principal amount of Securities that such Underwriter agreed to
purchase hereunder plus such Underwriter’s pro rata share (based on the
principal amount of Securities that such Underwriter agreed to purchase hereunder) of the
Securities of such defaulting Underwriter or Underwriters for which such arrangements have
not been made.
(c) If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Underwriter or Underwriters by the non-defaulting
25
Underwriters and the Company as provided in paragraph (a) above, the aggregate
principal amount of such Securities that remains unpurchased exceeds one-eleventh of the
aggregate principal amount of all the Securities, or if the Company shall not exercise the
right described in paragraph (b) above, then this Agreement shall terminate without
liability on the part of the non-defaulting Underwriters. Any termination of this Agreement
pursuant to this Section 10 shall be without liability on the part of the Company, except
that the Company will continue to be liable for the payment of expenses as set forth in
Section 11 hereof and except that the provisions of Section 7 hereof shall not terminate and
shall remain in effect.
(d) Nothing contained herein shall relieve a defaulting Underwriter of any liability it
may have to the Company or any non-defaulting Underwriter for damages caused by its default.
11. Payment of Expenses. (a) Whether or not the transactions contemplated by this
Agreement are consummated or this Agreement is terminated, the Company will pay or cause to be paid
all costs and expenses incident to the performance of its obligations hereunder, including without
limitation, (i) the costs incident to the authorization, issuance, sale, preparation and delivery
of the Securities and any taxes payable in that connection; (ii) the costs incident to the
preparation, printing and filing under the Securities Act of the Registration Statement, the
Preliminary Prospectus, any Issuer Free Writing Prospectus, any Time of Sale Information and the
Prospectus (including all exhibits, amendments and supplements thereto) and the distribution
thereof; (iii) the costs of reproducing and distributing each of the Transaction Documents; (iv)
the fees and expenses of the Company’s counsel and independent accountants; (v) the fees and
expenses incurred in connection with the registration or qualification and determination of
eligibility for investment of the Securities under the laws of such jurisdictions as the
Representatives may designate and the preparation, printing and distribution of a Blue Sky
Memorandum (including the related reasonable fees and expenses of counsel for the Underwriters);
(vi) any fees charged by rating agencies for rating the Securities; (vii) the fees and expenses of
the Trustee and any paying agent (including related reasonable fees and expenses of any counsel to
such parties); (viii) all expenses and application fees incurred in connection with any filing
with, and clearance of any offering by, the Financial Industry Regulatory Authority, Inc.; and (ix)
all expenses incurred by the Company in connection with any “road show” presentation to potential
investors.
(b) If (i) this Agreement is terminated pursuant to Section 9, (ii) the Company for any
reason fails to tender the Securities for delivery to the Underwriters or (iii) the
Underwriters decline to purchase the Securities for any reason permitted under this
Agreement, the Company agrees to reimburse the Underwriters for all out-of-pocket costs and
expenses (including the fees and expenses of their counsel) reasonably incurred by the
Underwriters in connection with this Agreement and the offering contemplated hereby.
26
12. Persons Entitled to Benefit of Agreement. This Agreement shall inure to the
benefit of and be binding upon the parties hereto and their respective successors and the officers
and directors and any controlling persons referred to herein, and the affiliates of each
Underwriter referred to in Section 7 hereof. Nothing in this Agreement is intended or shall be
construed to give any other person any legal or equitable right, remedy or claim under or in
respect of this Agreement or any provision contained herein. No purchaser of Securities from any
Underwriter shall be deemed to be a successor merely by reason of such purchase.
13. Survival. The respective indemnities, rights of contribution, representations,
warranties and agreements of the Company and the Underwriters contained in this Agreement or made
by or on behalf of the Company or the Underwriters pursuant to this Agreement or any certificate
delivered pursuant hereto shall survive the delivery of and payment for the Securities and shall
remain in full force and effect, regardless of any termination of this Agreement or any
investigation made by or on behalf of the Company or the Underwriters.
14. Certain Defined Terms. For purposes of this Agreement, (a) except where otherwise
expressly provided, the term “affiliate” has the meaning set forth in Rule 405 under the Securities
Act; (b) the term “business day” means any day other than a day on which banks are permitted or
required to be closed in New York City; and (c) the term “subsidiary” has the meaning set forth in
Rule 405 under the Securities Act.
15. Miscellaneous. (a) Authority of the Representatives. Any action by the
Underwriters hereunder may be taken by the Representatives on behalf of the Underwriters, and any
such action taken by the Representatives shall be binding upon the Underwriters.
(b) Notices. All notices and other communications hereunder shall be in writing and
shall be deemed to have been duly given if mailed or transmitted and confirmed by any
standard form of telecommunication. Notices to the Underwriters shall be given to the
Representatives c/o X.X. Xxxxxx Securities Inc., 000 Xxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000
(fax: 000-000-0000); Attention: Investment Grade Syndicate Desk – 8th Floor, and Xxxxxxx,
Sachs & Co., 00 Xxxxx Xxxxxx, 00xx Xxxxx, Xxx Xxxx, Xxx Xxxx 00000, Attention: Registration
Department. Notices to the Company shall be given to it at the address of the Company set
forth in the Prospectus Supplement, Attention: Corporate Secretary.
(c) Governing Law. This Agreement shall be governed by and construed in accordance
with the laws of the State of New York.
(d) Counterparts. This Agreement may be signed in counterparts (which may include
counterparts delivered by any standard form of
27
telecommunication), each of which shall be an original and all of which together shall
constitute one and the same instrument.
(e) Amendments or Waivers. No amendment or waiver of any provision of this Agreement,
nor any consent or approval to any departure therefrom, shall in any event be effective
unless the same shall be in writing and signed by the parties hereto.
(f) Headings. The headings herein are included for convenience of reference only and
are not intended to be part of, or to affect the meaning or interpretation of, this
Agreement.
[Signature page follows]
28
If the foregoing is in accordance with your understanding, please indicate your acceptance of
this Agreement by signing in the space provided below.
Very truly yours, | ||||
DIAMOND OFFSHORE DRILLING, INC. | ||||
By: | /s/ Xxxxxxx X. Xxxx | |||
Name: Xxxxxxx X. Xxxx | ||||
Title: Senior Vice President, General Counsel and Secretary |
[Acceptance page follows]
[Signature page to Underwriting Agreement]
Accepted: April 29, 2009
X.X. XXXXXX SECURITIES INC.
XXXXXXX, SACHS & CO.
XXXXXXX, SACHS & CO.
For themselves and on behalf of the
several Underwriters listed
in Schedule 1 hereto.
several Underwriters listed
in Schedule 1 hereto.
X.X. XXXXXX SECURITIES INC. | ||||
By:
|
/s/ Xxxxx Xxxxxx
|
|||
Title: Executive Director | ||||
XXXXXXX, SACHS & CO. | ||||
By:
|
/s/ Xxxxxxx, Xxxxx & Co.
|
|||
Title: |
[Acceptance page to Underwriting Agreement]
Schedule 1
Underwriter | Principal Amount | |||
X.X. Xxxxxx Securities Inc. |
$ | 225,000,000 | ||
Xxxxxxx, Xxxxx & Co. |
225,000,000 | |||
Comerica Securities |
7,150,000 | |||
Fortis Securities LLC |
7,150,000 | |||
HSBC Securities (USA) Inc. |
7,150,000 | |||
Mitsubishi UFJ Securities (USA), Inc. |
7,150,000 | |||
Mizuho Securities USA Inc. |
7,150,000 | |||
UniCredit Capital Markets, Inc. |
7,125,000 | |||
Wachovia
Capital Markets, LLC |
7,125,000 | |||
Total |
$ | 500,000,000 | ||
Schedule 2
TIME OF SALE INFORMATION
1. | Preliminary Prospectus Supplement dated April 29, 2009. | |
2. | Pricing Term Sheet dated April 29, 2009 in the form set forth in Schedule 3. |
Schedule 3
Diamond Offshore Drilling, Inc.
Pricing Term Sheet
Issuer: |
Diamond Offshore Drilling, Inc. | |
Size: |
$500,000,000 | |
Maturity: |
May 1, 2019 | |
Coupon: |
5.875% | |
Price to Public: |
99.851% | |
Yield to Maturity: |
5.895% | |
Spread to Benchmark Treasury: |
2.875% | |
Benchmark Treasury: |
2.750% due February 15, 2019 | |
Benchmark Treasury Yield: |
3.020% | |
Interest Payment Dates: |
May 1 and November 1, commencing November 1, 2009 | |
Make-Whole Call: |
Treasury Rate plus 45 basis points | |
Trade Date: |
April 29, 2009 | |
Settlement Date: |
T+3; May 4, 2009 | |
CUSIP / ISIN: |
00000XXX0 / US25271CAK80 | |
Ratings:* |
Baa1 (stable) / A- (stable) | |
Joint Book-Running Managers: |
Xxxxxxx, Sachs & Co. | |
X.X. Xxxxxx Securities Inc. | ||
Co-Managers: |
Comerica Securities | |
Fortis Securities LLC | ||
HSBC Securities (USA) Inc. | ||
Mitsubishi UFJ Securities (USA), Inc. | ||
Mizuho Securities USA Inc. | ||
UniCredit Capital Markets, Inc. | ||
Xxxxx Fargo Securities, LLC |
* | Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. |
The issuer has filed a registration statement (including a prospectus) with the SEC for the
offering to which this communication relates. Before you invest, you should read the prospectus in
that registration statement and other documents the issuer has filed with the SEC for more complete
information about the issuer and this offering. You may get these documents for free by visiting
XXXXX on the SEC Web site at xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer
participating in the offering will arrange to send you the prospectus if you request it by calling
X.X. Xxxxxx Securities Inc. collect at 000-000-0000 or Xxxxxxx, Xxxxx & Co. toll-free at
0-000-000-0000.
Any disclaimer or other notice that may appear below is not applicable to this communication and
should be disregarded. Such disclaimer or notice was automatically generated as a result of this
communication being sent by Bloomberg or another email system.
Schedule 4
Name | Jurisdiction of Organization | |
Diamond Offshore Company
|
Delaware | |
Diamond Offshore Finance Company
|
Delaware | |
Diamond Offshore General Company
|
Delaware | |
Diamond Offshore Management Company
|
Delaware | |
Diamond Offshore Services Company
|
Delaware | |
Diamond Offshore (Trinidad) L.L.C.
|
Delaware | |
Diamond Offshore (USA) LLC
|
Delaware |
Annex A
[Form of Opinion of Counsel for the Company]
1. The Registration Statement is an “automatic shelf registration statement” as defined under
Rule 405 of the Securities Act that has been filed with the Commission not earlier than three years
prior to the date hereof; the Indenture has been qualified under the Trust Indenture Act; each of
the Preliminary Prospectus and the Prospectus was filed with the Commission pursuant to the
subparagraph of Rule 424(b) under the Securities Act specified in such opinion on the date
specified therein; and to such counsel’s knowledge, (a) no order suspending the effectiveness of
the Registration Statement has been issued, (b) no notice of objection of the Commission to the use
of such registration statement or any post-effective amendment thereto pursuant to Rule 401(g)(2)
under the Securities Act has been received by the Company and (c) no proceeding for that purpose or
pursuant to Section 8A of the Securities Act against the Company or in connection with the offering
contemplated by the Prospectus has been initiated or overtly threatened by the Commission.
2. The Registration Statement, the Preliminary Prospectus, each Issuer Free Writing Prospectus
included in the Time of Sale Information and identified on Schedule 2 hereto and the Prospectus and
any amendments or supplements thereto made prior to the date hereof (in each case other than the
financial statements and the notes thereto, the financial statement schedules and the other
financial and accounting data included therein or which should be included therein, as to which
such counsel need express no opinion) comply as to form in all material respects with the
requirements of the Securities Act; and the Indenture complies as to form in all material respects
with the requirements of the Trust Indenture Act.
3. The Company is a corporation validly existing and in good standing under the laws of the
State of Delaware and has all requisite corporate power and authority to own, lease and operate its
properties and to carry on its business as described in the Registration Statement, Time of Sale
Information and the Prospectus.
4. The documents incorporated by reference in the Registration Statement, Time of Sale
Information and the Prospectus (in each case other than the financial statements and the notes
thereto, the financial statement schedules and other financial and accounting data included therein
or which should be included therein, as to which such counsel need express no opinion), when they
were filed with the Commission, complied as to form in all material respects with the requirements
of the Exchange Act, and the rules and regulations of the Commission thereunder.
5. The Company has the requisite corporate power and authority to authorize, issue and sell
the Securities as contemplated by this Agreement. The Securities have been duly authorized,
executed, authenticated, issued and delivered and, when paid for by the Underwriters pursuant to
the Underwriting Agreement, will constitute valid and
A-1
legally binding obligations of the Company entitled to the benefits provided by the Indenture;
and the Securities and the Indenture conform in all material respects to the descriptions thereof
in the Registration Statement, Time of Sale Information and the Prospectus.
6. The Company has all requisite corporate power and authority to execute and deliver the
Indenture and this Agreement, to issue, sell and deliver the Securities to the Underwriters
pursuant to the Indenture and this Agreement and to perform its other obligations thereunder and
hereunder. The execution, delivery and performance of the Indenture and this Agreement by the
Company have been duly authorized by all necessary corporate action on the part of the Company.
This Agreement has been duly and validly executed and delivered by the Company. The Indenture has
been duly and validly executed and delivered by the Company and (assuming the due authorization,
execution and delivery thereof by the other parties thereto) constitutes the legal, valid and
binding obligation of the Company, enforceable against it in accordance with its terms, subject to
applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and similar
laws affecting creditors’ rights and remedies generally, and subject, as to enforceability, to
general principles of equity, including principles of commercial reasonableness, good faith and
fair dealing (regardless of whether enforcement is sought in a proceeding at law or in equity),
except that (A) rights to indemnification and contribution thereunder may be limited by federal or
state securities laws or public policy relating thereto and (B) no opinion need be expressed with
respect to any provision of the Indenture providing for liquidated damages.
7. The execution and delivery by the Company of the Indenture and this Agreement and the
performance by the Company of its obligations thereunder and hereunder and the issuance and sale of
the Securities pursuant to the Indenture and this Agreement will not conflict with, constitute a
breach or default under or violate (i) any of the terms, conditions or provisions of the Amended
and Restated Certificate of Incorporation or Amended and Restated By-laws, as amended, of the
Company, (ii) any New York, Texas, Delaware corporate or federal law or regulation (other than
federal securities laws, as to which such counsel need express no opinion in this paragraph, and
state securities laws or blue sky laws and the Shipping Act, 1916, as amended, as to which such
counsel need express no opinion), or (iii) any judgment, writ, injunction, decree, order or ruling
of any court or governmental authority binding on the Company of which such counsel is aware.
8. No consent, approval, waiver, license or authorization or other action by or filing with
any New York, Texas or Delaware corporate or federal governmental authority is required in
connection with the execution and delivery by the Company of this Agreement or the Indenture,
issuance and sale of Securities or the consummation by the Company of the transactions contemplated
thereby or hereby or the performance by the Company of its obligations contemplated thereunder or
hereunder, except for filings, consents and other actions required under or pursuant to federal
securities laws,
A-2
as to which such counsel need express no opinion in this paragraph and state securities or
blue sky laws as to which such counsel need express no opinion.
9. The statements set forth in the Prospectus and Time of Sale Information under the captions
“Description of the Notes” and “Description of Debt Securities,” insofar as they purport to
constitute a summary of the terms of the Securities, under the caption “Certain United States
Federal Tax Consequences”, and under the caption “Underwriting”, insofar as they purport to
describe the provisions of the laws of the States of New York and Texas, the General Corporation
Law of the State of Delaware or the federal laws of the United States, and documents referred to
therein, constitute fair summaries thereof in all material respects.
10. The Company is not an “investment company,” as such term is defined in the Investment
Company Act of 1940, as amended.
In rendering such opinion, such counsel may rely as to matters of fact on certificates of
responsible officers of the Company and public officials that are furnished to the Underwriters.
The opinion of Xxxxx Xxxxxx LLP described above shall be rendered to the Underwriters at the
request of the Company and shall so state therein.
X-0
Xxxxx X
[00x-0 Xxxxxxxxx of Counsel for the Company]
Counsel for the Company shall state that they have reviewed the Registration Statement, the
Time of Sale Information and the Prospectus and have participated in conferences with
representatives of the Company, its independent public accountants, the Representatives and their
counsel, at which conferences the contents of the Registration Statement, the Time of Sale
Information and the Prospectus and related matters were discussed.
Such counsel shall confirm to you that, on the basis of the information they gained in the
course of performing the services referred to above, no facts have come to their attention which
cause them to believe that the Registration Statement, at the Effective Time (including the
information, if any, deemed pursuant to Rule 430A, 430B or 430C to be part of the Registration
Statement at the Effective Time) contained an untrue statement of a material fact or omitted to
state a material fact required to be stated therein or necessary to make the statements therein not
misleading, that the Time of Sale Information, at the Time of Sale (which such counsel may assume
to be the date of the this Agreement), contained any untrue statement of a material fact or omitted
to state a material fact necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading or that the Prospectus or any amendment or
supplement thereto as of its date and the Closing Date contained or contains any untrue statement
of a material fact or omits to state a material fact necessary to make the statements therein, in
the light of the circumstances under which they were made, not misleading (in each case other than
the financial statements and the related notes thereto, the financial statement schedules and the
other financial and accounting data included therein or which should be included therein, as to
which such counsel need express no view).
B-1
Annex C
[Form of Opinion of General Counsel for the Company]
1. The Company is duly qualified as a foreign corporation and is in good standing in each
jurisdiction where the character of its activities requires such qualification, except where the
failure by the Company to be so qualified would not have a material adverse effect on the business,
results of operations or financial condition of the Company and its subsidiaries, taken as a whole.
2. Except for directors’ qualifying shares, all of the issued and outstanding shares of
capital stock or membership interests, as applicable, of (i) each subsidiary of the Company listed
on Schedule 4 hereto (each, a “Subsidiary” and collectively, the “Subsidiaries”) and (ii) to such
counsel’s knowledge, Diamond Offshore Limited, a company organized under the laws of England and
Wales, Diamond Offshore International Limited, a Cayman Islands company, and Diamond Offshore
Drilling Limited, a Cayman Islands company, are owned, directly or indirectly, of record and
beneficially by the Company (except for directors’ qualifying shares), free and clear of all liens,
claims, limitations on voting rights, options, security interests and other encumbrances and have
been duly authorized and validly issued and are fully paid and non-assessable.
3. Each Subsidiary is a corporation or limited liability company, as applicable, validly
existing and in good standing, under the laws of its jurisdiction of incorporation or formation.
Each Subsidiary is duly qualified as a foreign corporation or limited liability company, as
applicable, and is in good standing in the states listed by such Subsidiary’s name on the attached
Schedule 4 (such states being the only states in which each such Subsidiary is required to be
qualified, except where the failure to be so qualified would not have a material adverse effect on
the business, results of operations or financial condition of the Company and its subsidiaries,
taken as a whole).
4. The execution and delivery by the Company of the Indenture and this Agreement and the
performance by the Company of its obligations thereunder and hereunder and the issuance and sale of
the Securities to the Underwriters hereunder and the compliance by the Company with all the
provisions of the Indenture and this Agreement and the consummation of the transactions
contemplated thereby and hereby will not conflict with, constitute a breach or a default under or
violate (i) any of the terms, conditions or provisions of the certificate of incorporation or
by-laws or comparable governing documents of any of the Subsidiaries, (ii) any of the terms,
conditions or provisions of any document, agreement or other instrument to which the Company or any
of the Subsidiaries is a party or by which the Company or any of the Subsidiaries is bound or to
which any of the properties of the Company or any of the Subsidiaries is subject except any such
conflict, breach, default or violation which would not, individually or in the aggregate, have a
material adverse effect on the business, results
C-1
of operations or financial condition of the Company and its subsidiaries, taken as a whole or
(iii) any judgment, writ, injunction, decree, order or ruling of any court or governmental
authority binding on any of the Subsidiaries.
5. To such counsel’s knowledge, (A) there are no current or pending legal or governmental
proceedings that would be required by the Securities Act to be described in the Registration
Statement or the Prospectus and that are not so described in the Registration Statement, the Time
of Sale Information and the Prospectus and (B) there are no statutes, regulations or contracts and
other documents that are required under the Securities Act to be filed as exhibits to the
Registration Statement or described in the Registration Statement or the Prospectus and that have
not been so filed as exhibits to the Registration Statement or described in the Registration
Statement, the Time of Sale Information and the Prospectus.
6. Except as disclosed in the Registration Statement, the Time of Sale Information and the
Prospectus, there is no litigation, proceeding or governmental investigation pending or, to such
counsel’s knowledge, overtly threatened against the Company or any of its subsidiaries or to which
any of the property of the Company or any of its subsidiaries is subject which, in such counsel’s
opinion, if adversely determined would, individually or in the aggregate, have a material adverse
effect on the business, assets, results of operations or financial condition of the Company and its
subsidiaries, taken as a whole.
7. No consent or approval of any federal governmental agency with respect to any federal
maritime law matter is required in connection with performance by the Company of its obligations
under this Agreement or the issuance and sale of the Securities. Neither the issuance, offer, sale
or delivery by the Company of the Securities pursuant to this Agreement nor the execution, delivery
and performance thereof by the Company or consummation of the transactions contemplated thereby,
will violate any existing federal maritime laws, including, without limitation, the Shipping Act,
1916, as amended, and the rules and regulations of the Maritime Administration and the United
States Coast Guard.
8. The Company is not in violation of its Amended and Restated Certificate of Incorporation
or its Amended and Restated By-Laws, as amended, or in default in the performance or observance of
any material obligation, covenant or condition contained in any indenture, mortgage, deed of trust,
loan agreement, lease or other agreement or instrument to which it is a party or by which it or any
of its properties may be bound, except for any such defaults that would not, individually or in the
aggregate, have a material adverse effect on the business, results of operations or financial
conditions of the Company and its subsidiaries, taken as a whole.
9. The Company has an authorized capitalization as set forth in the Registration Statement,
Time of Sale Information and the Prospectus, and all of the
C-2
issued shares of capital stock of the Company have been duly and validly authorized and issued
and are fully paid and non-assessable.
Such counsel may state that the opinions expressed in paragraphs 1 and 3 above are given solely on
the basis of the respective certificates of good standing (or other evidence in writing) (the “Good
Standing Certificates”), and speak only as of the respective dates of the Good Standing
Certificates rather than the date of such opinions. Such opinions may be limited to the meaning
ascribed to each such Good Standing Certificate by the respective public official that issued such
Good Standing Certificate and applicable law.
C-3